Biomarkers for Parkinson's disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21508309.
- Also identified by DOI 10.1126/scitranslmed.3002488.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biomarkers for detecting the early stages of Parkinson's disease (PD) could accelerate development of new treatments. Such biomarkers could be used to identify individuals at risk for developing PD, to improve early diagnosis, to track disease progression with precision, and to test the efficacy of new treatments. Although some progress has been made, there are many challenges associated with developing biomarkers for detecting PD in its earliest stages.
Medical subject headings
- Biomarkers
- Disease Progression
- Parkinson Disease